Filed April 30, 2025

Serial No. 79432372

Examining Attorney null

Class Pharmaceutical preparations and products for the prevention and treatment of disorders and diseases in, generated from or affecting the central nervous system; pharmaceutical preparations and substances that act on the central nervous system; central nervous system stimulants; pharmaceutical preparations and products for the diagnosis, prevention and/or treatment of psychiatric, neurological, neurohormonal, neuroendocrinological and autoimmune diseases and disorders; pharmaceutical preparations and products for the diagnosis, prevention and treatment of alzheimer's disease, depression, psychosis, anxiety, lennox-gastaut disease, epilepsy, dravet syndrome, development and epileptic encephalopathy (DEE), alphasynucleinopathies, sclerosis, multiple system atrophy (MSA), dementia with lewy bodies, REM sleep behavior syndrome, porphyria, huntington's disease, insomnia, parkinson's disease, schizophrenia, bipolar disorder, oncology, pain, migraine, headache, cluster headache, traumatic brain injury, post-traumatic brain injury, dizziness, seizures, stroke, cognitive impairment, cognitive disorders and diseases, mood swings, falls, movement disorders and movement disorders, tremor, agitation, mania, aggression, autism, melancholia, OCD, tourette's syndrome, restlessness, akathisia, fatigue, drowsiness, nausea, cushing's disease, adrenogenital syndrome (AGS), narcolepsy, PTSD, ADHD, PSP, thyroid associated orbitopathy (TAO), graves' orbitopathy, hashimoto's thyroiditis, alcoholism and addiction; diagnostic preparations for medical purposes, reagents for medical diagnostic and medical purposes; and diagnostic agents and reagents for medical purposes; 005; 006; 018; 044; 046; 051; 052; 021; 023; 026; 036; 038; 100; 101; 102; 100; 101; 102; 100; 101; 104; 100; 101; 107; 100; 101; 100; 101

Case Type Trademark Service mark